DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0238461 | Anaplastic thyroid carcinoma | ICAM1 | 3383 | intercellular adhesion molecule 1 | P05362 |
C0238461 | Anaplastic thyroid carcinoma | LGALS3 | 3958 | galectin 3 | P17931 |
C0238461 | Anaplastic thyroid carcinoma | MMUT | 4594 | methylmalonyl-CoA mutase | P22033 |
C0238461 | Anaplastic thyroid carcinoma | PIK3CD | 5293 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | O00329 |
C0238461 | Anaplastic thyroid carcinoma | BCKDHB | 594 | branched chain keto acid dehydrogenase E1 subunit beta | P21953 |
C0238461 | Anaplastic thyroid carcinoma | SCD | 6319 | stearoyl-CoA desaturase | O00767 |
C0238461 | Anaplastic thyroid carcinoma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
C0238461 | Anaplastic thyroid carcinoma | CAT | 847 | catalase | P04040 |
C0238461 | Anaplastic thyroid carcinoma | CD1D | 912 | CD1d molecule | P15813 |
C0238461 | Anaplastic thyroid carcinoma | CD44 | 960 | CD44 molecule (Indian blood group) | P16070 |
C0238461 | Anaplastic thyroid carcinoma | HK2 | 3099 | hexokinase 2 | P52789 |
C0238461 | Anaplastic thyroid carcinoma | GLO1 | 2739 | glyoxalase I | Q04760 |
C0238461 | Anaplastic thyroid carcinoma | IDH2 | 3418 | isocitrate dehydrogenase (NADP(+)) 2 | P48735 |
C0238461 | Anaplastic thyroid carcinoma | PGD | 5226 | phosphogluconate dehydrogenase | P52209 |
C0238461 | Anaplastic thyroid carcinoma | PIK3CA | 5290 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | P42336 |
C0238461 | Anaplastic thyroid carcinoma | IL18R1 | 8809 | interleukin 18 receptor 1 | Q13478 |
C0238461 | Anaplastic thyroid carcinoma | CDH13 | 1012 | cadherin 13 | P55290 |
C0238461 | Anaplastic thyroid carcinoma | CLC | 1178 | Charcot-Leyden crystal galectin | Q05315 |
C0238461 | Anaplastic thyroid carcinoma | CYP19A1 | 1588 | cytochrome P450 family 19 subfamily A member 1 | P11511 |
C0238461 | Anaplastic thyroid carcinoma | CYP24A1 | 1591 | cytochrome P450 family 24 subfamily A member 1 | Q07973 |
C0238461 | Anaplastic thyroid carcinoma | ACACA | 31 | acetyl-CoA carboxylase alpha | Q13085 |
C0238461 | Anaplastic thyroid carcinoma | L1CAM | 3897 | L1 cell adhesion molecule | P32004 |
C0238461 | Anaplastic thyroid carcinoma | PIK3CB | 5291 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | P42338 |
C0238461 | Anaplastic thyroid carcinoma | PIK3CG | 5294 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | P48736 |
C0238461 | Anaplastic thyroid carcinoma | PKD1 | 5310 | polycystin 1, transient receptor potential channel interacting | P98161 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024